Natural health product · NPN 80089961
TamaFlex
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed January 7, 2019; licence last revised January 27, 2025.
- Natural Product Number (NPN)
- 80089961
- Licence holder
- NXT USA, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- January 7, 2019
- Licence last revised
- January 27, 2025
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Curcuma longa | 15 milligrams | Rhizome; 15 % Curcuminoids; 7-12:1.0 Dry; equivalent to 105-180 milligrams dried herb |
| Tamarindus indica | 30 milligrams | Seed(s); 90 % Proanthocyanidins; 8-12:1.0 Dry; equivalent to 240-360 milligrams dried herb |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Provides antioxidants for the maintenance of good health. Helps to improve joint health by reducing knee joint pain, knee joint stiffness and improving physical function associated with daily physical activity/mild to moderate osteoarthritis of the knee. Helps to reduce/relieve knee joint pain associated with daily physical activity/mild to moderate osteoarthritis of the knee. Helps to reduce knee stiffness associated with daily physical activity/mild to moderate osteoarthritis of the knee. Helps to promote joint comfort associated with daily physical activities/mild to moderate osteoarthritis of the knee. Helps to promote joint movement and physical functioning associated with daily physical activity/mild to moderate osteoarthritis of the knee by reducing joint pain and stiffness. Helps to improve ability to perform daily activities by reducing joint stiffness. Helps relieve joint pain associated with daily physical activity in 14 days. Helps relieve joint pain associated with mild to moderate osteoarthritis of the knee in 5 days. Clinically proven to provide relief from joint stiffness/pain associated with mild to moderate osteoarthritis of the knee in as little as 5 days. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation associated with osteoarthritis of the knee. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation associated with osteoarthritis of the knee. Helps to reduce blood C reactive protein levels, a clinical marker of inflammation.
Non-medicinal ingredients
Silicon dioxide; Hypromellose; Microcrystalline cellulose